Mark Shearman

Mark Shearman

Verkställande Direktör på
Aprinoia Therapeutics, Inc. /US/
64 år
Health Technology
Consumer Services

Profil

Mark S.
Shearman
is currently the Chief Executive Officer & Director at Aprinoia Therapeutics, Inc. He previously held positions as the Executive Director-Neuroscience at Merck & Co., Inc., the Executive Director at Merck Research Laboratories Massachusetts LLC, and the Senior Director-Cellular & Molecular Neuroscience at Merck Sharp & Dohme Research Laboratories Neuroscience Research.
He also served as the Senior VP-Research & Early Development at Merck KGaA and the Chief Scientific Officer & Vice President at Beacon Therapeutics (USA), Inc. Dr. Shearman's most recent former position was as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. He received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.

Aktiva positioner av Mark Shearman

FöretagPositionStart
Verkställande Direktör 2023-07-14

Tidigare kända positioner av Mark Shearman

FöretagPositionSlut
APPLIED GENETIC TECHNOLOGIES CORPORATION Teknisk/Vetenskaplig/F&U Direktör 2021-04-20
MERCK KGAA Företagsledare/Principal 2015-01-01
Direktör/Styrelseledamot 2009-07-01
MERCK & CO., INC. Företagsledare/Principal 2009-01-01
Merck Sharp & Dohme Research Laboratories Neuroscience Researc
Företagsledare/Principal 2005-01-01
Se detaljerna i Mark Shearmans erfarenhet

Mark Shearmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

86

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Merck Sharp & Dohme Research Laboratories Neuroscience Researc

Health Technology

  1. Börsen
  2. Insiders
  3. Mark Shearman